ArticlePharmaceutics2019

Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant.

Dulce Bento et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.